Cited by 71Cystic Fibrosis Research AdvancesCardiac Health and Mental HealthMental Health Treatment and Access

Decreased survival in cystic fibrosis patients with a positive screen for depression

Open access
Schechter, Michael S., Ostrenga, Joshua S., Fink, Aliza K., Barker, David H., Sawicki, Gregory S., Quittner, Alexandra L.·2021·Journal of Cystic Fibrosis

Abstract

Background The International Depression Epidemiological Study (TIDES) found elevated rates of screen positivity for depression and anxiety among individuals with cystic fibrosis (CF). Depression is associated with worse adherence and health-related quality of life in CF. We investigated the relationship with mortality. Methods Subjects were untransplanted participants in TIDES 12+ years of age receiving care at one of 45 collaborating US CF care centers who completed the Hospital Anxiety and Depression Scale and/or Center for Epidemiologic Studies Depression Scale during a stable visit between 2006 and 2010. Clinical characteristics and mortality data were obtained from the CF Foundation Patient Registry. The association of a positive screen with 5-year survival was evaluated using Cox Proportional Hazards modeling. Results Of 1005 eligible patients, 25% screened positive for depression and 34% screened positive for anxiety. Patients who screened positive for depression were more likely to be older, have a residual function mutation, public insurance, and more pulmonary exacerbations in the screening year. There were 96 deaths. The unadjusted 5-year Hazard Ratio (HR) for death among those with depression was 2.0; 95% CI (1.3, 3.0)]. When adjusted for predetermined potential confounders the HR for the entire population was 1.4; 95% CI (0.9, 2.2). The adjusted HR was higher in adults [1.6; 95% CI (1.0, 2.4)] and those screening in the severe range [2.0; 95% CI (1.2, 3.4)]. Anxiety was not associated with mortality. Conclusions A positive depression screen is associated with increased mortality among adults with CF. Research into the etiology of this relationship is needed.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jcf.2020.07.020

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 35 references couldn’t be matched to a known paper.

Research works printed but not linked: 2

  1. Mills JC , Pence BW , Todd JV , Bengtson AM , Breger TL , Edmonds A , et al. Cumu- lative burden of depression and all-cause mortality in women living with HIV. Clin Infect Dis 2018;67:1575-81 .
  2. Hilliard ME , Eakin MN , Borrelli B , Green A , Riekert KA . Medication beliefs me- diate between depressive symptoms and medication adherence in cystic fibro- sis. Health psychology: official journal of the Division of Health Psychology. Am Psychol Assoc 2015;34:496-504 .

Cited by

Sorted by citations

Authors
Schechter, M. S., Ostrenga, J. S., Fink, A. K., Barker, D. H., Sawicki, G. S., & Quittner, A. L.
Affiliations
  • Virginia Commonwealth University (US)
  • Cystic Fibrosis Foundation (US)
  • Rhode Island Hospital (US)
  • Boston Children's Hospital (US)
  • Miami Children's Hospital (US)
Corresponding author
Schechter, Michael S.
Venue
Journal of Cystic Fibrosis
Publisher
Elsevier BV
Published
2021-01
Volume
20
Issue
1
Pages
120-126
ISSN
1569-1993 (ISSN-L)
OpenAlex
W3048599506
Cited by
71
References
35
Citations by year
2026: 11 · 2025: 9 · 2024: 12 · 2023: 13 · 2022: 13 · 2021: 9 · 2020: 3
FWCI
5.36
Type
journal article
Language
en
Open access
Locations
  • Journal of Cystic Fibrosis (publishedVersion)
  • PubMed (publishedVersion)
Funders
Cystic Fibrosis Foundation
Topics
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cystic Fibrosis Research Advances
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Health and Mental Health
  • Social Sciences › Psychology › Social Psychology › Mental Health Treatment and Access
Keywords
depression, anxiety, mortality, depression screening, Hospital Anxiety and Depression Scale, Center for Epidemiologic Studies Depression Scale, tides, adults with cystic fibrosis
MeSH terms
Adolescent, Anxiety, Cystic Fibrosis, Depression, Female, Humans, Male, Survival Rate

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review